Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein S12 pseudogene 10 (RPS12P10) is a non-functional genetic element in the human genome, derived from the ribosomal protein S12 gene, which is a component of the 40S ribosomal subunit required for protein synthesis[1][4]. RPS12P10 is classified as a processed pseudogene, formed by retrotransposition and lacking normal protein-coding capacity. While the parent gene RPS12 plays roles in ribosome assembly, translation accuracy, and cellular homeostasis[1][2][3], pseudogenes like RPS12P10 do not contribute functional protein and have no established physiological, pathological or therapeutic relevance. These pseudogenes are broadly distributed throughout the genome and do not encode receptors, enzymes, or other druggable targets[4]. If you are seeking information about a therapeutic target, you should refer to the functional ribosomal protein S12 (RPS12), not this pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein S12 pseudogene 10 (RPS12P10).